MOBILE   |  REGISTER   |   LOGIN   |   HELP
HOME  |  ABOUT US  |  BLOGGERS  |  BLOGS  |  MESSAGES  |  VIDEO  |  QUIZZES  |  LIBRARY  |  WEBINARS
A Gated Community for Oncology Nurses and
Cancer Care Teams | More Info
Breast   |   Prostate   |   Lung   |   Hematology   |   Skin   |   Gastrointestinal   |   Genitourinary   |   Head / Neck   |   Brain   |   Gynecological   |   Sarcoma   |   Thyroid
Career  |  Exercise  |  Nutrition  |  Recipes  |  Survivorship  |  Symptom Management  |  Emergencies  |  Side Effects  |  Pediatrics  |  Complementary Therapies
Hematologic cancers
most recent users' messages
Blog Roll
Deborah A. Boyle

Deborah A. Boyle
Myelodysplastic Syndrome in the Elderly
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
2/21/2017  0
Myelodysplastic syndrome (MDS) is primarily a hematological malignancy of aging. Eighty percent of cases are diagnosed in adults > age 70 who experience considerable symptom burden ...

Deborah A. Boyle

Deborah A. Boyle
Relentless Fatigue
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
1/26/2017  1
Of all the potential toxicities of cancer therapy, fatigue is the one side effect all patients can expect to encounter. It most recently has been the focus of increasing ...

Most recent post: CMG... Login to View
Deborah A. Boyle

Deborah A. Boyle
Adherence to Oral Cancer Drugs: The Key to Optimum Treatment Outcomes
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
1/18/2017  0
I remember more than 2 decades ago having lunch with a radiation oncologist who specialized in breast cancer therapy. In this early era of prophylactic tamoxifen therapy she said to ...

Deborah A. Boyle

Deborah A. Boyle
The Good News/Bad News Hodgkin Lymphoma Chronicle
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
11/29/2016  0
Hodgkin lymphoma accounts for approximately 16% of all malignancies in adolescents and young adults (between ages 15 and 39 years).1, 2 Its 5-year survival expectations currently ...

Carole McCue

Carole McCue
New Safety Guidelines for Vincristine Administration
Carole McCue, RN, MS, CNE
11/25/2016  0
Vincristine is a chemotherapeutic agent, administered intravenously (IV) to patients with blood cancers such as leukemia or lymphoma. It is highly effective in blocking cancer by ...

Deborah A. Boyle

Deborah A. Boyle
Understanding the Lymphoma and Leukemia Genetic Landscape
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
11/22/2016  0
When I first moved to metropolitan Washington, DC in 1992, I attended an oncology nursing conference at the National Cancer Institute. I remember hearing a pediatric immunologist ...

Deborah A. Boyle

Deborah A. Boyle
A Novel Treatment Landscape Unfolds: Oncology Nurses Take Note
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
11/8/2016  0
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in western countries.1-4 Accounting for nearly one-third of all leukemias in the United States, CLL is ...

Lori Smith

Lori Smith
UV Light Robots Reduce Clostridium Difficile Transmissions
Lori Smith, BSN, MSN, CRNP
10/18/2016  0
The stool culture result every practitioner dreads: Clostridium difficile (C. diff). Many of us have treated oncology patients with the condition and know what a toll the infection ...

Deborah A. Boyle

Deborah A. Boyle
Multiple Myeloma: The Mysterious Malignancy
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
9/28/2016  0
Multiple myeloma is a heterogeneous malignancy whose understanding and management have evolved significantly over the past decade. This cancer's complexity is in large part ...

Webinar Series
Tuesday, October 29, 2013 12:00 PM EDT
Archived

Presented by Ellen T. Matloff, MS, CGC , this webinar will highlight:

  • How to determine which patients require genetic counseling
  • How to help prepare your patients for the genetic counseling process
  • Testing options that are now available
  • How you can utilize this data in managing your patients and their family members

Participants will also be able to ask questions during a live question and answer period with speaker Ellen T. Matloff, MS, CGC .

Wednesday, August 28, 2013 12:00 PM EDT
Wednesday, June 26, 2013 12:00 PM EDT
Wednesday, April 10, 2013 12:00 PM EDT
Readerboards
Have a question or topic but don't want to write a blog? Post it on our readerboards and get feedback from the community!
Patriotacp on Cancer Patient Fall Prevention
Patriotacp on Enhance your Business through Excellent Website Promotion
Patriotacp on Enhance your Business through Excellent Website Promotion
FDA Approves Onivyde for Advanced Pancreatic Cancer
Marijke Vroomen Durning, RN,
10/27/2015  3
On October 22, 2015, the US Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection, Merrimack Pharmaceuticals, Inc.), in combination with fluorouracil ...
Like Us on Facebook
on Twitter
TheONC Twitter Feed
TheONC.org